Associations of CCR5-▵32 and CCR2-64I With NHL and Other AIDS Indicator Conditions in HIV-1–Infected Patients
. | No. of CCR5 +/+ . | No. of CCR5 +/Δ32 or Δ32/Δ32 . | Odds Ratio . | 95% CI . | No. of CCR2 +/+* . | No. of CCR2 +/64I or 64I/64I* . | Odds Ratio . | 95% CI . |
---|---|---|---|---|---|---|---|---|
NHL | 49 | 2 | 0.2 | (0.0-0.9) | 22 | 7 | 1.3 | (0.4-3.1) |
Kaposi’s sarcoma† | 23 | 3 | 0.7 | (0.1-2.9) | 22 | 3 | 0.5 | (0.1-2.1) |
Opportunistic infection‡ | 235 | 37 | 1.0 | (0.6-1.6) | 179 | 31 | 0.6 | (0.3-0.9) |
No AIDS indicator clinical conditions | 345 | 58 | 1.2 | (0.7-1.8) | 259 | 82 | 1.7 | (1.1-2.7) |
. | No. of CCR5 +/+ . | No. of CCR5 +/Δ32 or Δ32/Δ32 . | Odds Ratio . | 95% CI . | No. of CCR2 +/+* . | No. of CCR2 +/64I or 64I/64I* . | Odds Ratio . | 95% CI . |
---|---|---|---|---|---|---|---|---|
NHL | 49 | 2 | 0.2 | (0.0-0.9) | 22 | 7 | 1.3 | (0.4-3.1) |
Kaposi’s sarcoma† | 23 | 3 | 0.7 | (0.1-2.9) | 22 | 3 | 0.5 | (0.1-2.1) |
Opportunistic infection‡ | 235 | 37 | 1.0 | (0.6-1.6) | 179 | 31 | 0.6 | (0.3-0.9) |
No AIDS indicator clinical conditions | 345 | 58 | 1.2 | (0.7-1.8) | 259 | 82 | 1.7 | (1.1-2.7) |